The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Tyrosine Phosphorylation of VE-cadherin Prevents Binding of p120- and β-Catenin and Maintains the Cellular Mesenchymal State
Open accessAbstract
In several pathological conditions, epithelial cells demonstrate a breakdown of barrier function and acquire an invasive phenotype. Endothelial cells in particular are maintained in a mesenchymal state during the cell invasion phase of angiogenesis. We show here that tyrosine phosphorylation of the adherens junction protein VE-cadherin at two critical tyrosines, Tyr-658 and Tyr-731, via tyrosine kinase activation or phosphatase inactivation was sufficient to prevent the binding of p120- and beta-catenin, respectively, to the cytoplasmic tail of VE-cadherin. In fact, phosphorylation at either site led to the inhibition of cell barrier function. Cells expressing wild-type VE-cadherin showed decreased cell migration compared with cells lacking VE-cadherin, whereas expression of VE-cadherin with a simple phosphomimetic tyrosine-to-glutamic acid mutation of Y658E or Y731E was sufficient to restore the migratory response. These findings demonstrate that a single phosphorylation event within the VE-cadherin cytoplasmic tail is sufficient to maintain cells in a mesenchymal state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis
Gumbiner, B. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81279-9 · Cited by 3,471
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
Hicklin, D. J., & Ellis, L. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,007
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
Cavallaro, U., & Christofori, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1276 · Cited by 1,311
Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability
Eliceiri, B. P., Paul, R., Schwartzberg, P. L., Hood, J. D., Leng, J., & Cheresh, D. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80221-x · Cited by 813
Self-citationE-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C., & van Roy, F. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00301.x · Cited by 775
Perez-Moreno, M., Jamora, C., & Fuchs, E. (2003) · Cell · doi:10.1016/s0092-8674(03)00108-9 · Cited by 721
Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells
Esser, S., Lampugnani, M. G., Corada, M., Dejana, E., & Risau, W. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.13.1853 · Cited by 715
Regulation of E-cadherin/Catenin Association by Tyrosine Phosphorylation
Roura, S., Miravet, S., Piedra, J., de Herreros, A. G., & Duñach, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36734 · Cited by 603
Cited by
Gavard, J., & Gutkind, J. S. (2006) · Nature Cell Biology · doi:10.1038/ncb1486 · Cited by 1,018
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
The role of adherens junctions and VE-cadherin in the control of vascular permeability
Dejana, E., Orsenigo, F., & Lampugnani, M. G. (2008) · Journal of Cell Science · doi:10.1242/jcs.017897 · Cited by 986
Vestweber (2008) · doi:10.1161/atvbaha.107.158014 · Cited by 806
Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies
Claesson-Welsh, L., Dejana, E., & McDonald, D. M. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.11.006 · Cited by 631
Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier
Stamatovic, S., Keep, R., & Andjelkovic, A. (2008) · Current Neuropharmacology · doi:10.2174/157015908785777210 · Cited by 513
A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions
Zaidel-Bar, R., Milo, R., Kam, Z., & Geiger, B. (2007) · Journal of Cell Science · doi:10.1242/jcs.03314 · Cited by 475
Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis
Wallez, Y., & Huber, P. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.09.003 · Cited by 473
Orsenigo, F., Giampietro, C., Ferrari, A., Corada, M., Galaup, A., Sigismund, S., Ristagno, G., Maddaluno, L., Young Koh, G., Franco, D., et al. (2012) · Nature Communications · doi:10.1038/ncomms2199 · Cited by 456
NADPH Oxidase-Dependent Signaling in Endothelial Cells: Role in Physiology and Pathophysiology
Frey, R. S., Ushio–Fukai, M., & Malik, A. B. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2220 · Cited by 420
Angiopoietin-1 Prevents VEGF-Induced Endothelial Permeability by Sequestering Src through mDia
Gavard, J., Patel, V., & Gutkind, J. S. (2008) · Developmental Cell · doi:10.1016/j.devcel.2007.10.019 · Cited by 411
Wessel, F., Winderlich, M., Holm, M., Frye, M., Rivera-Galdos, R., Vockel, M., Linnepe, R., Ipe, U., Stadtmann, A., Zarbock, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2824 · Cited by 354
Endothelial permeability, LDL deposition, and cardiovascular risk factors—a review
Mundi, S., Massaro, M., Scoditti, E., Carluccio, M. A., van Hinsbergh, V. W. M., Iruela-Arispe, M. L., & De Caterina, R. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvx226 · Cited by 367
Leukocyte – endothelial interactions in inflammation
Langer, H. F., & Chavakis, T. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00811.x · Cited by 344
Allingham, M. J., van Buul, J. D., & Burridge, K. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4053 · Cited by 335
Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza
London, N. R., Zhu, W., Bozza, F. A., Smith, M. C. P., Greif, D. M., Sorensen, L. K., Chen, L., Kaminoh, Y., Chan, A. C., Passi, S. F., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000678 · Cited by 330
Broken Barriers: A New Take on Sepsis Pathogenesis
Goldenberg, N. M., Steinberg, B. E., Slutsky, A. S., & Lee, W. L. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002011 · Cited by 324
The FGF system has a key role in regulating vascular integrity
Murakami, M., Nguyen, L. T., Zhang, Z. W., Moodie, K. L., Carmeliet, P., Stan, R. V., & Simons, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35298 · Cited by 303
Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium
Vestweber, D. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00533.x · Cited by 295
VE-cadherin: at the front, center, and sides of endothelial cell organization and function
Harris, E. S., & Nelson, W. J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.07.006 · Cited by 291
Passing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation
Wettschureck, N., Strilic, B., & Offermanns, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00037.2018 · Cited by 286
Mechanisms Regulating Endothelial Permeability
Sukriti, S., Tauseef, M., Yazbeck, P., & Mehta, D. (2014) · Pulmonary Circulation · doi:10.1086/677356 · Cited by 283
Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player
Vestweber, D., Winderlich, M., Cagna, G., & Nottebaum, A. F. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.10.001 · Cited by 283
The Role of VE-Cadherin in Vascular Morphogenesis and Permeability Control
Dejana, E., & Vestweber, D. (2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-394311-8.00006-6 · Cited by 203
Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration
Turowski, P., Martinelli, R., Crawford, R., Wateridge, D., Papageorgiou, A.-P., Lampugnani, M. G., Gamp, A. C., Vestweber, D., Adamson, P., Dejana, E., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.022681 · Cited by 169
CCL2 disrupts the adherens junction: implications for neuroinflammation
Roberts, T. K., Eugenin, E. A., Lopez, L., Romero, I. A., Weksler, B. B., Couraud, P.-O., & Berman, J. W. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.80 · Cited by 115
“Antibodies to Y658 of VE-cadherin and Y654 of β-catenin, sites of c-Src phosphorylation (66, 67), were used to evaluate phosphorylation.”
MethodStochastic non-enzymatic modification of long-lived macromolecules - A missing hallmark of aging
Fedintsev, A., & Moskalev, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101097 · Cited by 72
Crippa, M., Bersini, S., Gilardi, M., Arrigoni, C., Gamba, S., Falanga, A., Candrian, C., Dubini, G., Vanoni, M., & Moretti, M. (2021) · Lab on a Chip · doi:10.1039/d0lc01011a · Cited by 37
Metadata
- Authors
- Potter, M. D., Barbero, S., & Cheresh, D. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 280
- Issue
- 36
- Pages
- 31906-31912
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2068793465
- Cited by
- 337
- References
- 36
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.